đź’¨ Abstract
Protalix BioTherapeutics Inc. (PLX) reported a net loss of $3.6 million for the first quarter of 2025, equating to a 5-cent loss per share. Despite this, the company generated $10.1 million in revenue for the period. The announcement was made in Hackensack, New Jersey. The report was generated using data from Zacks Investment Research.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Charges dropped against 3 officers after they make a training video about fatal Colorado shooting -
Ucrania dice que descubriĂł una red de espionaje hĂşngara que opera en una regiĂłn de sus fronteras -
Indigenous fashion week in Santa Fe, New Mexico, explores heritage in silk and hides -
To keep millions alive after aid cuts, pull climate and other funding in richer nations, group says -
AP PHOTOS: Statue of late Motorhead frontman Lemmy unveiled in English hometown -
Doctor Reddy’s: Fiscal Q4 Earnings Snapshot -
England’s record six teams in next Champions League set to fuel wealth gap in European soccer -
Wisconsin dad charged in school shooting is latest parent accused in gun violence -
Trump revives, then discards, then revives again the idea of taxing the rich in big GOP bill -
Turkish Airlines Open Par Scores -
Powered by MessengerX.io